As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
FDA Announces More Flexible Approach to CGT Regulation
January 13, 2026
REGULATORY UPDATE: FDA Releases 2026 CBER Guidance Agenda
January 12, 2026
Free CABP Exam Retake Offer Ends Friday
January 06, 2026